Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA

Human Gene Therapy

Volumn 10, Issue 3, 1999, Pages 407-417

  Schultz, Jan ^a   Pavlovic, Jovan ^a   Strack, Bettina ^a   Nawrath, Michael ^a   Moelling, Karin ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; PLASMID DNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL LINE; LUNG METASTASIS; MELANOMA; METASTASIS; METASTASIS INHIBITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; TRANSGENIC MOUSE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE TRANSFER TECHNIQUES; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-12; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TIME FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0033540621     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018850     Document Type: Article

References (56)

1. BOYER, J.D., UGEN, K.E., WANG, B., AGADJANYAN, M., GILBERT, L., BAGARAZZI, M.L., CHATTERGOON, M., FROST, P., JAVADIAN, A., WILLIAMS, W.V., REFAELI, Y., CICCARELLI, R.B., McCALLUS, D., CONEY, L., and WEINER, D.B. (1997). Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med. 3, 526-532.
2. CHAN, S.H., PERUSSIA, B., GUPTA, J.W., KOBAYASHI, M., POSPISIL, M., YOUNG, H.A., WOLF, S.F., YOUNG, D., CLARK, S.C., and TRINCHIERI, G. (1991). Induction of IFN-γ production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173, 869-879.
3. CHU, R.S., TARGONI, O.S., KRIEG, A.M., LEHMANN, P.V., and HARDING, C.V. (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186, 1623-1631.
4. COHEN, J. (1995). IL-12 deaths: Explanation and a puzzle. Science 270, 908.
5. CONRY, R.M., LOBUGLIO, A.F., LOECHEL, F., MOORE, S.E., SUMEREL, L.A., BARLOW, D.L., and CURIEL, D.T. (1995). A carcinoembryonic antigen polynucleotide vaccine has in vivo anti-tumor activity. Gene Ther. 2, 59-65.
6. CONRY, R.M., WIDERA, G., LOBUGLIO, A.F., FULLER, J.T., MOORE, S.E., BARLOW, D.L., TURNER, J., YANG, N.S., and CURIEL, D.T. (1996). Selected strategies to augment polynucleotide immunization. Gene Ther. 3, 67-74.
7. α14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626.
8. DELAMARTER, J.F., MERMOD, J.J., LIANG, C.M., ELIASON, J.F., and THATCHER, D.R. (1985). Recombinant murine GM-CSF from E. coli has biological activity and is neutralized by a specific anti-serum. EMBO J. 4, 2575-2581.
9. DOEHRING, C., ANGMAN, L., SPAGNOLI, G., and LANZAVECCHIA, A. (1994). T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int. J. Cancer 57, 754-759.
10. DONNELLY, J.J., FRIEDMAN, A., MARTINEZ, D., MONTGOMERY, D.L., SHIVER, J.W., MOTZEL, S.L., ULMER, J.B., and LIU, M.A. (1995). Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift on influenza virus. Nature Med. 1, 583-587.
11. DONNELLY, J.J., ULMER, J.B., and LIU, M.A. (1997). DNA vaccines. Life Sci. 60, 163-172.
12. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.
13. EUGSTER, H.P., MULLER, M., KARRER, U., CAR, B.D., SCHNYDER, B., ENG, V.M., WOERLY, G., LE HIR, M., DI PADOVA, F., AGUET, M., ZINKERNAGEL, R., BLUETHMANN, H., and RYFFEL, B. (1996). Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int. Immunol. 8, 23-36.
14. FIDLER, I.J. (1973). Selection of successive tumour lines for metastasis. Nature New. Biol. 242, 148-149.
15. FIDLER, I.T., and HART, I.R. (1981). Biological and experimental consequences of the zonal composition of solid tumors. Cancer Res. 41, 3266-3267.
16. FREEMAN, G.J., GRAY, G.S., GIMMI, C.D., LOMBARD, D.B., ZHOU, L.J., WHITE, M., FINGEROTH, J.D., GRIBBEN, J.G., and NADLER, L.M. (1991). Structure expression and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174, 625-631.
17. FUNG-LEUNG, W.P., SCHILHAM, M.W., RAHEMTULLA, A., KUNDIG, T.M., VOLLENWEIDER, M., POTTER, J., VAN EWIJK, W., and MAK, T.W. (1991). CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65, 443-449.
18. GALLARDO, H.F., TAN, C., and SADELAIN, M. (1997). The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes. Gene Ther. 4, 1115-1119.
19. GATELY, M.K., WARRIER, R.R., HONASOGE, S., CARVAJAL, D.M., FAHERTY, D.A., CONNAUGHTON, S.E., ANDERSON, T.D., SARMIENTO, U., HUBBARD, B.R., and MURPHY, M. (1994). Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol. 6, 157-167.
20. HEINZEL, F.P., RERKO, R.M., LING, P., HAKIMI, J., and SCHOENHAUT, D. (1994). Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 62, 4244-4249.
21. HEUFLER, C., KOCH, F., and SCHULER, G. (1987). GM-CSF and IL-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory cells. J. Exp. Med. 167, 700-705.
22. HUANG, S., HENDRIKS, W., ALTHAGE, A., HEMMI, S., BLUETHMANN, H., KAMIJO, R., VILCEK, J., ZINKERNAGEL, R.M., and AGUET, M. (1993). Immune response in mice that lack the interferon-γ receptor. Science 259, 1742-1745.
23. INABA, K., INABA, M., ROMANI, N., AYA, H., DEGUCHI, M., IKEHARA, S., MURAMATSU, S., and STEINMAN, R.M. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702.
24. IRVINE, K.R., RAO, J.B., ROSENBERG, ST.A., and RESTIFO, N.P. (1996). Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156, 238-245.
25. KAGI, D., LEDERMANN, B., BURKI, K., SEILER, P., ODERMATT, B., OLSEN, K.J., PODACK, E.R., ZINKERNAGEL, R.M., and HENGARTNER, H. (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (London) 369, 31-37.
26. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
27. LIPFORD, G., SPARWASSER, T., BAUER, M., ZIMMERMANN, S., KOCH, E.S., HEEG, K., and WAGNER, H. (1997). Immunostimulatory DNA: Sequence dependent production of potentially harmful or useful cytokines. Eur. J. Immunol. 27(12), 3420-3426.
28. LIU, M.A., HILLEMAN, M.R., and KURTH, R., eds. (1995). DNA Vaccines: A New Era in Vaccinology. (New York Academy of Sciences, New York).
29. LOLLINI, P.-L., BOSCO, M.C., CAVALLO, F., DE GIOVANNI, C., GIOVARELLI, M., LANDUZZI, L., MUSIANI, P., MODESTI, A., NICOLETTI, G., PALMIERI, G., SANTONI, A., YOUNG, H.A., FORNI, G., and NANNI, P. (1993). Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int. J. Cancer 565, 320-329.
30. LOWIN, B., BEERMANN, F., SCHMIDT, A., and TSCHOPP, J. (1994). A null mutation in the perform gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 91, 11571-11575.
31. MANTHORPE, M., CORNEFERT-JENSEN, F., HARTIKKA, J., FELGNER, J., RUNDELL, A., MARGALITH, M., and DWARKI, V. (1993). Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4, 419-431.
32. MARSHALL, E. (1995). Cancer trial of interleukin-12 halted. Science 268, 1555.
33. MICHEL, M.L., DAVIS, H.L., SCHLEF, M., MANCINI, M., TIOLLAIS, P., and WHALEN, R.G. (1995). DNA-mediated immunization to the hepatitis B surface antigen in mice: Aspects of the humoral response mimic hepatitis B viral infection in human. Proc. Natl. Acad. Sci. U.S.A. 92, 5307-5311.
34. MOELLING, K., STRACK, B., NAWRATH, M., DOEHRING, C., WAGNER, N.S., and PAVLOVIC, J. (1997). Development of a DNA vaccine against malignant melanoma. In Strategies for Immunointervention in Dermatology. G. Burg and R. Dummer, eds. (Springer-Verlag, New York) pp. 195-206.
35. MONTGOMERY, D.L., SHIVER, J.W., LEANDER, K.R., PERRY, H.C., PRIEDMAN, A., MARTINEZ, D., ULMER, J.B., DONNELLY, J.J., and LIU, M.A. (1993). Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors. DNA Cell Biol. 9, 777-783.
36. NASTALA, C.L., EDINGTON, H.D., MCKINNEY, T.G., TAHARA, H., NALESNIK, M.A., BRUNDA, M.J., GATELY, M.K., WOLF, S.F., SCHREIBER, R.D., STORKUS, W.J., and LOTZE, M.T. (1994). Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153, 1697-1706.
37. NICOLSON, G.L., DULSKI, K.M., BASSON, C., and WELCH, D.R. (1985). Preferential organ attachment and invasion in vitro by B 16 melanoma cells selected for differing colonization and invasive properties. Invasion Metastasis 5, 144-158.
38. NOGUCHI, Y., RICHARDS, E.C., CHEN, Y.T., and OLD, L.J. (1995). Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc. Natl. Acad. Sci. U.S.A. 92, 2219-2223.
39. ORANGE, J.S., SALAZAR-MATHER, T.P., OPAL, S.M., SPENCER, R.L., MILLER, A.H., McEWEN, B.S., and BIRON, C.A. (1995). Mechanism ofinterleukin-12 mediated cytotoxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181, 901-914.
40. PUTZER, B.M., HITT, M., MULLER, W.J., EMTAGE, P., GAULDIE, J., and GRAHAM, F.L. (1997). Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression. Proc. Natl. Acad. Sci. U.S.A. 94, 10889-10894.
41. RAKHMILEVICH, A.L., JANSSEN, K., TURNER, J., CULP, J., and YANG, N.S. (1997). Cytokine gene therapy of cancer using gene gun technology: Superior antitumor activity of Interleukin-12. Hum. Gene Ther. 8, 1303-1311.
42. ROSENBERG, S.A., YANG, J.C., SCHWARTZENTRUBER, D.J., HWU, P., MARINCOLA, F.M., TOPALIAN, S.L., RESTIFO, N.P., DUDLEY, M.E., SCHWARZ, S.L., SPIESS, P.J., WUNDERLICH, J.R., PARKHURST, M.R., KAWAKAMI, Y., SEIPP, C.A., EINHORN, J.H., and WHITE, D.E. (1998). Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Med. 4, 321-324.
43. SCHOENHAUT, D.S., CHUA, A.O., WOLITZKY, A.G., QUINN, P.M., DWYER, C.M., McCOMAS, W., FAMILLETTI, P.C., GATELY, M.K., and GUBLER, U. (1992). Cloning and expression of murine IL-12. J. Immunol. 148, 3433-3440.
44. SMOLLER, B.R., McNUTT, N.S., and HSU, A. (1988). HMB-45 recognizes stimulated melanocytes. J. Cutan. Pathol. 16, 49-53.
45. 1 plus complement in vitro on cytotoxic T cell activities. J. Immunol. 136, 4674.
46. TAHARA, H., ZITVOGEL, L., STORKUS, W.J., ZEH, H.J., III, McKINNEY, T.G., SCHREIBER, R.D., GUBLER, U., ROBBINS, P.D., and LOTZE, M.T. (1995). Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154, 6466-6474.
47. TAO, M.H., and LEVY, R. (1993). Idiotype/granulocyte-macrophage colony stimulating factor fusion protein as a vaccine candidate for B-cell lymphoma. Nature (London) 362, 755-758.
48. TRINCHIERI, G. (1994). Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008-4027.
49. TRINCHIERI, G. (1995). Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity. Annu. Rev. Immunol. 13, 251.
50. TSUJI, T., HAMAJIMA, K., FUKUSHIMA, J., XIN, K.Q., ISHII, N., AOKI, I., ISHIGATSUBO, Y., TANI, K., KAWAMOTO, S., NITTA, Y., MIYAZAKI, J., KOFF, W.C., OKUBO, T., and OKUDA, K. (1997). Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158, 4008-4013.
51. ULMER, J.B., DONNELLY, J.J., PARKER, S.E., RHODES, G.H., FELGNER, P.L., DWARKI, V.J., GROMKOWSKI, S.H., DECK, R.R., DEWITT, C.M., FRIEDMAN, A., HAWE, L.A., LEANDER, K.R., MARTINEZ, D., PERRY, H.C., SHIVER, J.W., MONTGOMERY, D.L., and LIU, M.A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
52. WAGNER, S.N., WAGNER, C., HOFLER, H., ATKINSON, M.J., and GOOS, M. (1995). Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45 - Identification as melanocyte-specific Pmel17 cDNA. Lab. Invest. 73, 229-235.
53. WANG, B., UGEN, K.E., SRIKANTAN, V., AGADJANYAN, M.G., DANK, K., REFAELI, Y., SATO, A.I., BOYER, J., WILLIAMS, W.V., and WEINER, D.B. (1993). Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 90, 4156-4160.
54. WEXLER, H. (1966). Accurate identification of experimental pulmonary metastases. J. Natl. Cancer Inst. 36, 641-645.
55. XIANG, Z., and ERTL, H.C.J. (1995). Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129-135.
56. ZITVOGEL, L., TAHARA, H., ROBBINS, P.D., STORKUS, W.J., CLARKE, M.R., NALESNIK, M.A., and LOTZE, M.T. (1995). Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J. Immunol. 155, 1393-1403.